About Inbio OÜ
Inbio Ltd is a biotechnology company based on Estonian private capital. Inbio was established by four leading biotechnology experts in Estonia in 1999.
* Located on campus of Tallinn Technical University
* Closely partnering with cancer drug discovery and development company Celecure
* Established academic multi-disciplinary skills base
* Team of 30 professionals including PhD-s from Oxford University, Karolinska Institutet other internationally renowned universities
* Inbiolabs values its employees and the community and works to safeguard health and the environment in all its activities
We provide custom antibody services and peptide synthesis. Inbio’s team has ten years of experience in antibody production. We also carry out research and development in the field of cell-membrane penetrating antibody technologies and diagnostic and therapeutic intrabodies.
Other branch of Inbio’s activities is providing contract research services for preclinical research
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of Inbio OÜ
Similar companies
Here you will find Inbio OÜ
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
